SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : DRKOOP.Com,Inc - (Nasdaq - KOOP) -- Ignore unavailable to you. Want to Upgrade?


To: Duke-N-Duke who wrote (592)8/4/2000 5:07:39 PM
From: Jack Hartmann  Read Replies (1) | Respond to of 595
 
Milberg Weiss Announces Class Action Suit Against
Dr.koop.com, Inc.

The following was released today by Milberg Weiss Bershad Hynes & Lerach LLP:

NEW YORK--(BUSINESS WIRE)--Aug. 4, 2000-- To Dr.koop.com, Inc.Security Purchasers:

On July 20, 2000, a complaint was filed, alleging violations of the federal securities laws by Dr.koop.com, Inc. (NASDAQ:
KOOP - news) and certain of its officers and/or directors. The class action was commenced in the United States District Court,
for the Western District of Texas, Austin Division on behalf of purchasers of Dr.koop.com securities during the period between
June 8, 1999 and March 30, 2000, inclusive.

The complaint charges that defendants violated Sections 11, 12(a)(2) and 15 of the Securities Act of 1933, and Sections 10(b)
and 20(a) of the Securities Exchange Act of 1934, and Rule 10b-5 promulgated thereunder, by making materially false and
misleading statements in their Initial Public Offering Prospectus, and to the market. A copy of the complaint can be obtained
from the Court, or can be viewed on Milberg Weiss' website at milberg.com

If you bought the securities of Dr.koop.com between June 8, 1999 and March 30, 2000, you may, no later than September
12, 2000, request that the Court appoint you as lead plaintiff. A lead plaintiff is a representative party that acts on behalf of
other class members in directing the litigation. You may retain Milberg Weiss Bershad Hynes & Lerach LLP to serve as your
counsel in this action by signing up on our website or by contacting us at the number listed below.

If you wish to discuss this action with us, or have any questions concerning this notice or your rights and interests with regard to
the case, please contact the following attorneys:

Steven G. Schulman or Samuel H. Rudman One Pennsylvania Plaza, 49th Floor, New York, NY,10119-0165 Phone
Number: (800) 320-5081 Website: milberg.com Email:drkoopcase@milbergNY.com

Contact:

Milberg Weiss Bershad Hynes & Lerach LLP
Steven G. Schulman or Samuel H. Rudman
800/320-5081
drkoopcase@milbergNY.com

****************
Any another suit that probably will make some lawyer rich.
Jack